Skip to main content
. 2019 Dec 19;34(4):e23151. doi: 10.1002/jcla.23151

Figure 2.

Figure 2

Integrin α7 expressions in AML patients with different risk stratification. A, comparison of ITGA7 mRNA expression among AML patients with favorable‐risk stratification, AML patients with intermediate‐risk stratification and AML patients with poor‐risk stratification; B, the examples of ITGA7 protein expression in AML patients with favorable risk, intermediate risk, and poor risk; C, comparison of ITGA7 protein expression among AML patients with favorable‐risk stratification, AML patients with intermediate‐risk stratification and AML patients with poor‐risk stratification. Correlation analyses were determined by Spearman's rank correlation test. P value <.05 was considered as significant. ITGA7, integrin α7; AML, acute myeloid leukemia